Although the knowledge about the genetic factors contributing to AD has greatly evolved throughout the years to understand the pathological process of AD9, the only approved drugs for AD treatment are cholinesterase inhibitors and an antagonist of the N-methyl-D-aspartate receptor, which can inhibit the symptoms but not reverse AD progression10. This evidence concerns the gene BCHE and Alzheimer disease.